Researchers have significantly advanced its development of the novel treatment for amyloid heart disease, utilizing Attruby. Early trial information reveals potential benefits for patients affected by the serious illness. This effort underscores BridgeBio's dedication to managing unmet medical needs in a heart field. Attruby: BridgeBio'… Read More